Lataa...
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past two decades. RNAi-based therapeutics including siRNA and shRNA have immense scope to silence the expression of mutant cancer genes specifically in a therapeutic context. Although tremendous progress ha...
Tallennettuna:
| Julkaisussa: | Pharmaceutics |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026921/ https://ncbi.nlm.nih.gov/pubmed/29861465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics10020065 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|